Examination of ELISA against PCR for assessing treatment efficacy against Cryptosporidium in a clinical trial context.
<h4>Background</h4>Cryptosporidium is a gastrointestinal pathogen that presents a serious opportunistic infection in immunocompromised individuals including those living with human immunodeficiency syndrome. The CRYPTOFAZ trial, previously published, was conducted in Malawi to evaluate t...
| Published in: | PLoS ONE |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2023-01-01
|
| Online Access: | https://doi.org/10.1371/journal.pone.0289929 |
